287 related articles for article (PubMed ID: 29631594)
1. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
[TBL] [Abstract][Full Text] [Related]
2. A novel antisense oligonucleotide anchored on the intronic splicing enhancer of hTERT pre-mRNA inhibits telomerase activity and induces apoptosis in glioma cells.
Wang F; Cheng Y; Zhang C; Chang G; Geng X
J Neurooncol; 2019 May; 143(1):57-68. PubMed ID: 30887243
[TBL] [Abstract][Full Text] [Related]
3. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
[TBL] [Abstract][Full Text] [Related]
4. Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells.
Brambilla C; Folini M; Gandellini P; Daprai L; Daidone MG; Zaffaroni N
Cell Mol Life Sci; 2004 Jul; 61(14):1764-74. PubMed ID: 15241552
[TBL] [Abstract][Full Text] [Related]
5. Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer.
Liu Y; Wu BQ; Zhong HH; Tian XX; Fang WG
PLoS One; 2012; 7(6):e38868. PubMed ID: 22723897
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation.
Liu WJ; Zhang YW; Zhang ZX; Ding J
J Pharmacol Sci; 2004 Oct; 96(2):106-14. PubMed ID: 15467265
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas.
Tchirkov A; Rolhion C; Kémény JL; Irthum B; Puget S; Khalil T; Chinot O; Kwiatkowski F; Périssel B; Vago P; Verrelle P
Br J Cancer; 2003 Feb; 88(4):516-20. PubMed ID: 12592364
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter.
Komata T; Kondo Y; Kanzawa T; Hirohata S; Koga S; Sumiyoshi H; Srinivasula SM; Barna BP; Germano IM; Takakura M; Inoue M; Alnemri ES; Shay JW; Kyo S; Kondo S
Cancer Res; 2001 Aug; 61(15):5796-802. PubMed ID: 11479218
[TBL] [Abstract][Full Text] [Related]
9. [Changes of alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis].
Xu JH; Wang YC; Geng X; Zhang WM
Ai Zheng; 2008 Dec; 27(12):1271-6. PubMed ID: 19079992
[TBL] [Abstract][Full Text] [Related]
10. Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing.
Gomez D; Lemarteleur T; Lacroix L; Mailliet P; Mergny JL; Riou JF
Nucleic Acids Res; 2004; 32(1):371-9. PubMed ID: 14729921
[TBL] [Abstract][Full Text] [Related]
11. Effect of antineoplastic agents on the expression of human telomerase reverse transcriptase beta plus transcript in MCF-7 cells.
Spiropoulou T; Ferekidou L; Angelopoulou K; Stathopoulou A; Talieri M; Lianidou ES
Clin Biochem; 2004 Apr; 37(4):299-304. PubMed ID: 15003732
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing of telomerase catalytic subunit hTERT generated by apoptotic endonuclease EndoG induces human CD4
Zhdanov DD; Vasina DA; Grachev VA; Orlova EV; Orlova VS; Pokrovskaya MV; Alexandrova SS; Sokolov NN
Eur J Cell Biol; 2017 Oct; 96(7):653-664. PubMed ID: 28886883
[TBL] [Abstract][Full Text] [Related]
13. [Study on expression of ING1, human telomerase reverse transcriptase and telomerase-associated protein 1 genes in human gliomas].
Yu SZ; Huang Y; Li L; Guan XQ; Zhang LX; An TL
Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):215-9. PubMed ID: 12882685
[TBL] [Abstract][Full Text] [Related]
14. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
Komata T; Koga S; Hirohata S; Takakura M; Germano IM; Inoue M; Kyo S; Kondo S; Kondo Y
Int J Oncol; 2001 Nov; 19(5):1015-20. PubMed ID: 11605003
[TBL] [Abstract][Full Text] [Related]
15. Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells.
Komata T; Kondo Y; Kanzawa T; Ito H; Hirohata S; Koga S; Sumiyoshi H; Takakura M; Inoue M; Barna BP; Germano IM; Kyo S; Kondo S
Hum Gene Ther; 2002 Jun; 13(9):1015-25. PubMed ID: 12067435
[TBL] [Abstract][Full Text] [Related]
16. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.
Ulaner GA; Hu JF; Vu TH; Oruganti H; Giudice LC; Hoffman AR
Int J Cancer; 2000 Feb; 85(3):330-5. PubMed ID: 10652422
[TBL] [Abstract][Full Text] [Related]
17. Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
Wang Y; Kowalski J; Tsai HL; Marik R; Prasad N; Somervell H; Lo PK; Sangenario LE; Dyrskjot L; Orntoft TF; Westra WH; Meeker AK; Eshleman JR; Umbricht CB; Zeiger MA
Thyroid; 2008 Oct; 18(10):1055-63. PubMed ID: 18816183
[TBL] [Abstract][Full Text] [Related]
18. [Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes].
Zhdanov DD; Vasina DА; Orlova EV; Orlova VS; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
Biomed Khim; 2017 Jan; 63(1):13-26. PubMed ID: 28251947
[TBL] [Abstract][Full Text] [Related]
19. Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients.
Rha SY; Jeung HC; Park KH; Kim JJ; Chung HC
Oncol Res; 2009; 18(5-6):213-20. PubMed ID: 20225759
[TBL] [Abstract][Full Text] [Related]
20. [Apoptotic endonuclease EndoG induces alternative splicing of telomerase catalytic subunit hTERT and death of tumor cells].
Zhdanov DD; Vasina DA; Orlova VS; Gotovtseva VY; Bibikova MV; Pokrovsky VS; Pokrovskaya MV; Aleksandrova SS; Sokolov NN
Biomed Khim; 2016 Mar; 62(3):239-50. PubMed ID: 27420614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
